Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp
Start free

DocGo Inc. (DCGO) Cash Flow Statement

DocGo Inc. (DCGO) generated -$22.7M of operating cash flow over the twelve months to 2026-06-30, spent $3.1M on capital expenditure and had free cash flow of -$25.8M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

DCGODocGo Inc.Follow DCGO — free
Medical Care Facilities · Healthcare
—
Price chart with a free account
Market cap
26.8M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
9 Nov, in 15 days
LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-1.928.9-64.570.134.5-22.7
Capital expenditure4.83.27.33.64.5-3.1
Free cash flow-6.825.7-71.866.529.9-25.8
Share repurchases—3.70.013.810.8—
Stock-based compensation——21.013.617.4—

USD millions · SEC XBRL

DocGo Inc. — questions

What is DocGo Inc.'s operating cash flow?
-$22.7M over the twelve months to 2026-06-30.
How much does DocGo Inc. spend on capital expenditure?
$3.1M over the twelve months to 2026-06-30.
What is DocGo Inc.'s free cash flow?
-$25.8M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from DocGo Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.